» Articles » PMID: 7547391

In Situ Hybridization Analysis of CRABP II Expression in Sebaceous Follicles from 13-cis Retinoic Acid-treated Acne Patients

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 1995 Aug 1
PMID 7547391
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the effects of 13-cis retinoic acid treatment on cellular retinoic acid binding protein II (CRABP II) mRNA expression in sebaceous follicles from acne patients, using in situ hybridization. Biopsies were taken from uninvolved skin areas in close juxtaposition to inflamed comedos before therapy, and at 2-4 or 14-16 weeks of treatment. Paraffin sections were used for in situ hybridization study with riboprobes transcribed from human CRABP II cDNA. After oral treatment with 13-cis retinoic acid, sebaceous glands were reduced in size and atrophic, and the ratio of sebum-free to fully differentiated (sebum-producing) sebocytes was dramatically increased. The CRABP II expression in the sebaceous gland, and to some extent in infundibular structures, was strongly increased compared with the level of expression in the epidermis. The maximum signal was always found in layers of suprabasal sebocytes lacking lipid droplets, but never in the basal layers. These findings indicate a selective activity of 13-cis retinoic acid on CRABP II mRNA expression in the sebaceous glands of acne patients.

Citing Articles

Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment.

Melnik B Cells. 2023; 12(22).

PMID: 37998335 PMC: 10670572. DOI: 10.3390/cells12222600.


Network Pharmacology and Molecular Modeling to Elucidate the Potential Mechanism of Neem Oil against .

Kola-Mustapha A, Raji M, Adedeji O, Ambrose G Molecules. 2023; 28(6).

PMID: 36985821 PMC: 10056471. DOI: 10.3390/molecules28062849.


Isotretinoin treatment upregulates the expression of p53 in the skin and sebaceous glands of patients with acne vulgaris.

Agamia N, El Mulla K, Alsayed N, Ghazala R, El Maksoud R, Abdelmeniem I Arch Dermatol Res. 2022; 315(5):1355-1365.

PMID: 36585988 PMC: 10205870. DOI: 10.1007/s00403-022-02508-y.


Isotretinoin and FoxO1: A scientific hypothesis.

Melnik B Dermatoendocrinol. 2011; 3(3):141-65.

PMID: 22110774 PMC: 3219165. DOI: 10.4161/derm.3.3.15331.


Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action.

Nelson A, Zhao W, Gilliland K, Zaenglein A, Liu W, Thiboutot D Dermatoendocrinol. 2010; 1(3):177-87.

PMID: 20436886 PMC: 2835911. DOI: 10.4161/derm.1.3.8258.